He Guixiang, director of Liangshan Prefecture Market Supervision Bureau, went to Huili City to carry out the quality and safety inspection of the new crown virus testing agent

In order to implement the requirements of the Sichuan Provincial Pharmaceutical Bureau on further strengthening the quality and safety supervision of the new coronary virus testing agent, and in -depth promotion of the implementation of the "first -hander" project, on July 22, He Guixiang, secretary of the party group and director of the Liangshan State Market Supervision and Administration Bureau, led the team to be in the same way. Municipal supervision and inspection of the quality and safety of the new coronary virus test agent.

The inspection team went into supervision and inspection of the new crown virus detection reagents and operating enterprises such as Huili City People's Hospital, Huili City Disease Control Center, and Huili Xin Da Pharmacy. It focuses on the qualifications of suppliers, product qualifications for testing reagents, purchase inspection records, cold chain transportation records, and monitoring of storage temperature. On -site inspection of inspection equipment, infrastructure, warehouses, personnel equipment, etc. At the same time, the quality management of medical equipment used by medical institutions also inspected the purchase, storage, sales and sales of antigen test reagents for one retail pharmacy operating enterprise. The implementation of the epidemic prevention and control requires the implementation of the spot check.

He Guixiang pointed out that the regulatory authorities should effectively improve their political standing, implement "strictest supervision" for the new crown virus testing agents, take resolute and powerful measures, strictly implement the main responsibility of enterprises and use units, effectively fulfill the responsibility for local territorial regulatory supervision, strengthen the new crown crown The quality and safety supervision of the product of the virus testing agent, the discovered illegal and illegal acts, seriously investigate and deal with it in accordance with the law, resolutely keep the quality and safety bottom line, consolidate the hard -won regulatory results, and provide a strong guarantee for the prevention and control of the epidemic.

He Guixiang requested that medical institutions should strictly control the quality of new crown virus nucleic acid testing agents, improve the quality management system of medical equipment, strictly review the qualifications of suppliers and product qualifications, and carefully implement the purchase inspection record system. Transport and storage reagents, implement full -process cold chain management, and effectively do quality management in the process of product procurement, acceptance, cold chain transportation, storage, and use to ensure the quality and safety of the use of new coronary virus nucleic acid test agents. (Mana Zeng Xuemei reporter Cheng Boquan)

- END -